Compare drug alternatives
Aimovig® Alternatives
Aimovig®
(Erenumab)
Aimovig
-
Migraine
- Emgality®
- Ajovy®
- Nurtec ODT®
- Ubrelvy®
- Qulipta®
Prescription Only
Aimovig is a prescription medication that adults can self-inject once a month under the skin to prevent migraine headaches. The most common side effects are injection site reactions and constipation. However, there are no reported instances of drug interactions with Aimovig.
Aimovig is FDA approved for the following indications: Migraine prevention.
Vyepti®
(eptinezumab-jjmr)
Vyepti
-
Migraine
- Emgality®
- Ajovy®
- Nurtec ODT®
- Ubrelvy®
- Qulipta®
Prescription Only
Vypeti is a prescription medication used for migraine prevention. It is administered as an intravenous infusion four times a year. The most common reported side effects were stuffy nose and scratchy throat.
Vyepti is FDA approved for the following indications: Migraine prevention.
Dosage & Administration
Administration
Subcutaneous
Intravenous infusion (must be diluted)
Dosing
70 mg once monthly or 140 mg once monthly (for some patients)
100 mg every 3 months or 300 mg (for some patients)
Latin Shorthand
70 mg/mo or 140 mg/mo
100 mg q3mo
Financial Assistance
Copay
$5
$0
Annual Cap
Patient specific maximum benefit.
$200 per infusion for administration costs
Assistance Expiration
Calendar year
Calendar year
Generics
No lower-cost generic available
No lower-cost generic available